semaglutide weight loss clinic mandarin Chinese biotech targets 2028 trial finish for spray using Wegovy's ingredient! Shanghai Shiling Pharmaceutical has announced plans to complete global clinical trials by 2028 for an innovative weight-management nasal spray that uses SEMAGLUTIDE WEIGHT LOSS - Strax

Obesity or Overweight With Weight-Related Conditions While not all GLP-1 medications are FDA-approved specifically for weight loss, some like Wegovy ( semaglutide ) are, and others including Mounjaro have shown substantial weight reduction benefits

However, Tiffany Ma, a board-certified sports dietitian based out of New York City with eight-plus years of experience, pointed out that there are no evidence-based studies or human clinical trials specifically examining creatine supplementation in individuals using GLP-1 medications at this time

Pipeline (Phase 3 trials completed, FDA decision pending as of April 2026): Survodutide (BI 456906): Dual GLP-1/glucagon agonist from Boehringer Ingelheim

Saxenda and Wegovy drug warnings Both Saxenda and Wegovy carry similar warnings and precautions